Skip to content
Sleep & circadian healthCohort study3 min read

Fragmented 24-hour activity rhythm linked to later brain amyloid, mostly in APOE4

MoveVitals Editorial Collective · Study published · Reading updated

Original paper:Sleep, 24-Hour Activity Rhythms, and Subsequent Amyloid-β Pathology. · JAMA neurology · 2024 · Original paper ↗

Key takeaway

In 319 adults without dementia, a more fragmented 24-hour activity rhythm at baseline was associated with more brain amyloid-β on PET 7.8 years later (β 0.15, 95% CI 0.04 to 0.26), more strongly in APOE4 carriers (β 0.38). No other sleep measure was associated, and calling fragmentation a modifiable risk factor is speculative.

Study design

Cohort study

Reading basis

Published abstract

Reading focus

Association & confounding

The research question

Sleep problems are common in older adults and have been tied to Alzheimer disease, including the build-up of amyloid-β in the brain. To prevent Alzheimer disease, it helps to know which sleep or daily-rhythm disturbance carries the most risk. The authors tested whether sleep and 24-hour activity rhythms predict later amyloid-β deposition, whether they come before it, and whether APOE4 genotype matters.

Who and how

Observational cohort within the Rotterdam Study. Of 639 participants without dementia who had amyloid-β positron emission tomography (PET, 18F-florbetaben) from September 2018 to November 2021, 319 with valid baseline actigraphy and APOE genotyping were included; baseline visits were 2004 to 2006 or 2012 to 2014, with mean follow-up of 7.8 years (SD 2.4). Exposures were 7 days of wrist actigraphy (objective sleep and 24-hour activity rhythms), sleep diaries, plasma Aβ42/40, p-tau181 and p-tau217, and APOE4 genotype. The outcome was cortical amyloid-β burden on PET at follow-up.

What it found

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    Participants had a mean age of 61.5 years at baseline and 69.2 at follow-up; 150 (47%) were women.
  2. 2
    Higher baseline intradaily variability, an indicator of fragmented 24-hour activity rhythms, was associated with higher amyloid-β PET burden at follow-up (β 0.15; bootstrapped 95% CI 0.04 to 0.26; P = .02; false discovery rate P = .048).
  3. 3
    The association was stronger in APOE4 carriers (β 0.38; 95% CI 0.05 to 0.64; P = .03) than in noncarriers (β 0.07; 95% CI -0.04 to 0.18; P = .19).
  4. 4
    Results stayed largely similar after excluding participants with Alzheimer pathology at baseline. No other objective or self-reported sleep measure was associated with amyloid-β.

Limits & uncertainty

  1. 1
    The main result is borderline after correcting for multiple testing (false discovery rate P = .048), and the APOE4 subgroup is small, so the estimate for carriers is imprecise (CI 0.05 to 0.64).
  2. 2
    Only 319 of 639 eligible participants were included, those with valid actigraphy and genotyping, so they may be healthier or more engaged than the full cohort.
  3. 3
    An observational link cannot show that fragmented rhythm causes amyloid build-up; the authors' suggestion that it is a modifiable risk factor is not tested here.
  4. 4
    This reading is based on the abstract only.

What to take from it

An irregular, broken-up pattern of daily rest and activity, more than sleep length or sleep quality scores, was the sleep-related marker tied to later amyloid in this group. It is a hint about prevention research, not a reason to worry about a single bad week or to expect that regularizing your routine will prevent Alzheimer disease. Memory concerns belong with a clinician.

Reading your own data

Wrist wearables capture a similar signal to the actigraphy used here, and some apps report rhythm regularity or consistency of bedtime and activity. Compare the same device over several weeks, and treat any such score as a general routine check, not a risk measure for Alzheimer disease.

How to read this evidence

Exposure precedes follow-up outcomes, but confounding and reverse causation can remain. A hazard ratio is not an individual absolute risk or a demonstrated intervention effect.

Authors’ structured abstract English

The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.

Importance

Sleep disturbances are common among older adults and have been associated with the development of Alzheimer disease (AD), such as amyloid-β (Aβ) pathology. For effective AD prevention, it is essential to pinpoint the specific disturbances in sleep and the underlying 24-hour activity rhythms that confer the highest risk of Aβ deposition.

Objective

To determine the associations of 24-hour activity rhythms and sleep with Aβ deposition in adults without dementia, to evaluate whether disrupted 24-hour activity and sleep may precede Aβ deposition, and to assess the role of the apolipoprotein E ε4 (APOE4) genotype.

Design, setting, and participants

This was an observational cohort study using data from the Rotterdam Study. Of 639 participants without dementia who underwent Aβ positron emission tomography (PET) from September 2018 to November 2021, 319 were included in the current study. Exclusion criteria were no APOE genotyping and no valid actigraphy data at the baseline visits from 2004 to 2006 or from 2012 to 2014. The mean (SD) follow-up was 7.8 (2.4) years. Data were analyzed from March 2023 to April 2024.

Exposures

Actigraphy (7 days and nights, objective sleep, and 24-hour activity rhythms), sleep diaries (self-reported sleep), Aβ42/40, phosphorylated tau (p-tau)181 and p-tau217 plasma assays, 18F-florbetaben PET (mean standard uptake value ratio [SUVR] in a large cortical region of interest), and APOE4 genotype.

Main outcomes and measures

Association of objective and self-reported sleep and 24-hour activity rhythms at baseline with brain Aβ PET burden at follow-up.

Results

The mean (range) age in the study population was 61.5 (48-80) years at baseline and 69.2 (60-88) years at follow-up; 150 (47%) were women. Higher intradaily variability at baseline, an indicator of fragmented 24-hour activity rhythms, was associated with higher Aβ PET burden at follow-up (β, 0.15; bootstrapped 95% CI, 0.04 to 0.26; bootstrapped P = .02, false discovery rate [FDR] P = .048). APOE genotype modified this association, which was stronger in APOE4 carriers (β, 0.38; bootstrapped 95% CI, 0.05 to 0.64; bootstrapped P = .03) compared to noncarriers (β, 0.07; bootstrapped 95% CI, -0.04 to 0.18; bootstrapped P = .19). The findings remained largely similar after excluding participants with AD pathology at baseline, suggesting that a fragmented 24-hour activity rhythm may have preceded Aβ deposition. No other objective or self-reported measure of sleep was associated with Aβ.

Conclusions and relevance

Among community-dwelling adults included in this study, higher fragmentation of the 24-hour activity rhythms was associated with greater subsequent Aβ burden, especially in APOE4 carriers. These results suggest that rest-activity fragmentation could represent a modifiable risk factor for AD.

Sources & attribution

Sleep, 24-Hour Activity Rhythms, and Subsequent Amyloid-β Pathology.

Nguyen Ho PT, Hoepel SJW, Rodriguez-Ayllon M, Luik AI, Vernooij MW, Neitzel J.

JAMA neurology · 2024-08-01

DOI: 10.1001/jamaneurol.2024.1755 ↗PubMed · 38913396 ↗Europe PMC · Recorded licence: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

MoveVitals editorial interpretation · educational content · no individual clinical review recorded

Sources checked 2026-11-01

Practical guides

Read in context

·Trial meta-analysis

Exercise improved sleep-quality scores in adults 45 and older with sleep disorders

Pooling 23 randomized trials with 1,478 adults aged 45 to 77 who had sleep disorders, exercise improved Pittsburgh Sleep Quality Index scores (SMD 0.62, 95% CI 0.40–0.83), and aerobic exercise showed the largest effect in the network analysis (SMD 1.34, 95% CrI 0.86–1.82). Certainty was low to moderate, the outcomes were questionnaires, and the best weekly dose of about 539 MET-min/week is a model estimate, not a prescription.

Journal of Exercise Science & Fitness

In-depth explainersRead study →
·Cohort study

Sleep regularity tracked mortality more closely than sleep duration in 60,977 UK adults

Among 60,977 UK Biobank adults who wore a wrist accelerometer for a week, the most regular fifth of sleepers had a fully adjusted all-cause mortality HR of 0.70 (95% CI 0.59–0.83) against the least regular fifth, over about 6.3 years and 1859 deaths. Regularity fitted the data better than sleep duration, but the study is observational and rests on one week of sleep data.

Sleep

In-depth explainersRead study →
·Randomised trial

Sleep extension cut daily energy intake by about 270 kcal in adults with overweight

In 80 adults with overweight who usually slept under 6.5 hours, two weeks of sleep-extension counselling added about 1.2 hours of sleep and lowered measured energy intake by 270.4 kcal/d versus control (95% CI −393.4 to −147.4). The trial was short, single-centre and in a narrow group, so it does not show lasting weight loss or any benefit for people who already sleep enough.

JAMA Internal Medicine

In-depth explainersRead study →
·Cohort study

Six hours or less of sleep at 50 and 60 linked to higher dementia risk

In 7959 British civil servants followed for about 25 years, sleeping six hours or less at age 50 (HR 1.22, 95% CI 1.01–1.48) or age 60 (HR 1.37, 1.10–1.72) was linked to a higher dementia rate than sleeping seven hours, and persistent short sleep gave an HR of 1.30 (1.00–1.69). Sleep was mostly self-reported and the study is observational, so early brain disease or other factors may explain part of the link.

Nature Communications

In-depth explainersRead study →
Sleep & circadian health →